Abstract
Purpose
Differentiated thyroid cancer (DTC) has an increasing incidence in childhood and adolescence but long-term outcome data are limited. We aimed to identify possible risk factors associated with disease persistence, with special focus on the usefulness of ATA risk stratification system and pre-ablation stimulated thyroglobulin (Tg) levels.
Methods
We retrospectively studied 103 patients, 79 females (76.7%), aged 15.6 ± 3.2 years (range 5–21 years) who underwent total thyroidectomy for DTC. Patients were classified by ATA risk stratification criteria as low, intermediate, and high risk for recurrence. All, except five with papillary microcarcinoma, received radioactive iodine (RAI) treatment.
Results
At diagnosis, 44.7% of patients had cervical lymph node and 7.8% pulmonary metastases. Amongst the 72 patients with long-term follow-up data, 31.9% had persistent disease. Lymph node as well as pulmonary metastases and increased pre-ablation stimulated thyroglobulin (Tg) levels were associated with persistent disease. The risk of persistent disease was significantly higher in both the intermediate- (OR 17.95; 95% CI 2.66–120.94, p < 0.01) and high-risk (OR 17.65; 95% CI 4.47–69.74, p < 0.001) groups. ROC curve analysis showed that a pre-ablation Tg level higher than 14 ng/ml had a sensitivity of 94.7% to predict persistence, corresponding to a positive (PPV) and negative predictive values (NPV) of 66.7% and 93.8%, respectively.
Conclusions
ATA risk stratification was validated in our population of children and young adults with DTC. Moreover, pre-ablation stimulated Tg levels of <14 ng/ml were associated with a low risk of long-term persistence and may therefore serve as a marker to identify patients who may need less intensive surveillance.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, OK, upon reasonable request.
References
J.W. Haveman, K.M. van Tol, C.W. Rouwe, D.A. Piers, J.T. Plukker, Surgical experience in children with differentiated thyroid carcinoma. Ann. Surg. Oncol. 10, 15–20 (2003)
A.R. Hogan, Y. Zhuge, E.A. Perez, L.G. Koniaris, J.I. Lew, J.E. Sola, Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J. Surg. Res. 156, 167–172 (2009)
E. Ward, C. DeSantis, A. Robbins, B. Kohler, A. Jemal, Childhood and adolescent cancer statistics, 2014. CA Cancer. J Clin 64, 83–103 (2014)
I.D. Hay, T. Gonzalez-Losada, M.S. Reinalda, J.A. Honetschlager, M.L. Richards, G.B. Thompson, Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J. Surg. 34, 1192–1202 (2010)
Y.E. Demidchik, E.P. Demidchik, C. Reiners, J. Biko, M. Mine, V.A. Saenko, S. Yamashita, Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann. Surg. 243, 525–532 (2006)
P. Papendieck, L. Grunero-Papendieck, M. Venara, O. Acha, S. Maglio, I. Bergadá, A. Chiesa, Differentiated thyroid carcinoma: presentation and follow-up in children and adolescents. J. Pediatr. Endocrinol. Metab. 24, 743–748 (2011)
A. Popovtzer, T. Shpitzer, G. Bahar, R. Feinmesser, K. Segal, Thyroid cancer in children: management and outcome experience of a referral center. Otolaryngol. Head Neck Surg. 135, 581–584 (2006)
V. Zaydfudim, I.D. Feurer, M.R. Griffin, J.E. Phay, The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144, 1070–1077 (2008)
M. Pawelczak, R. David, B. Franklin, M. Kessler, L. Lam, B. Shah, Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following 131I treatment: a systematic review. Thyroid 20, 1095–1101 (2010)
F. Vaisman, D.A. Bulzico, C.H. Pessoa, M.A. Bordallo, U.B. Mendonça, F.L. Dias, C.M. Coeli, R. Corbo, M. Vaisman, Prognostic factors of a good response to initial treatment in children and adolescents with differentiated thyroid cancer. Clinics 66, 281–286 (2011)
D. Zimmerman, I.D. Hay, I.R. Gough, J.R. Goellner, J.J. Ryan, C.S. Grant, W.M. McConahey, Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104, 1157–1166 (1988)
L. Lazar, Y. Lebenthal, A. Steinmetz, Yackobovitch-Gavan, M. Phillip, Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J. Pediatr. 154, 708–714 (2009)
M.P. La Quaglia, T. Black, G.W. Holcomb 3rd, C. Sklar, R.G. Azizkhan, G.M. Haase, K.D. Newman, Differentiated thyroid cancer; clinical characteristics, treatment and outcome in patients under 21 years of age who present with distant metastases. A report from the surgical discipline committee of the children’s cancer group. J. Pediatr. Surg. 35, 955–960 (2000)
R.C. Webb, R.S. Howard, A. Stojadinovic, D.Y. Gaitonde, M.K. Wallace, J. Ahmed, H.B. Burch, The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3947 patients. J. Clin. Endocrinol. Metab. 97, 2754–2763 (2012)
G.L. Francis, S.G. Waguespack, A.J. Bauer, P. Angelos, S. Benvenga, J.M. Cerutti, C.A. Dinauer, J. Hamilton, I.D. Hay, M. Luster, M.T. Parisi, M. Rachmiel, G.B. Thompson, S. Yamashita, American thyroid association guidelines task force. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25, 716–758 (2015)
T.Y. Sung, M.J. Jeon, Y.H. Lee, Y.M. Lee, H. Kwon, J.H. Yoon, K.W. Chung, W.G. Kim, D.E. Song, S.J. Hong, Initial and dynamic risk stratification of pediatric with differentiated thyroid cancer. J. Clin. Endocrinol. Metab 102, 793–800 (2017)
N. Bhavani, K. Bhadran, V. Nair, U.V. Menon, P.V. Pavithran, A.S. Menon, N. Abraham, A. Pankaj, H. Kumar, Treatment outcomes in pediatric differentiated thyroid carcinoma. J. Pediatr. Endocrinol. Metab 31, 1117–1122 (2018)
K. Kim, W.W. Kim, J.B. Choi, M.J. Kim, C.R. Lee, J. Lee, S.W. Kang, K.H. Nam, W.Y. Chung, J.J. Jeong, Usefulness of dynamic risk stratification in pediatric patients with differentiated thyroid carcinoma. Ann. Surg. Treat Res. 95, 222–229 (2018)
L. Lazar, Y. Lebenthal, K. Segal, A. Steinmetz, Y. Strenov, M. Cohen, I. Yaniv, M. Yackobovitch-Gavan, M. Phillip, Pediatric thyroid cancer: postoperative classifications and response-to-initial therapy as prognostic factors. J. Clin. Endocrinol. Metab. 101, 1970–1979 (2016)
A.B. Zanella, R.S. Scheffel, C.F. Nava, L. Golbert, E. Laurini de Souza Meyer, M. Punales, I. Gonçalves, J.M. Dora, A.L. Maia, Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer. Thyroid 28, 1285–1292 (2018)
L. Liu, F. Huang, B. Liu, R. Huang, Detection of distant metastases at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin. J. Pediatr. Endocrinol. Metab. 31, 751–756 (2018)
A. Zanella, R.S. Scheffel, M.W. Pasa, J.M. Dora, A.L. Maia, The role of postoperative stimulated thyroglobulin as prognostic factor for differentiated thyroid cancer in children and adolescents. Thyroid 27, 787–792 (2017)
M.J. Livhits, J.D. Pasternak, M. Xiong, N. Li, J.E. Gosnell, M.W. Yeh, H.K. Chiu, Pre-ablation thyroglobulin and thyroglobulin to thyroid-stimulating hormone ratio may be associated with pulmonary metastases in children with differentiated thyroid cancer. Endocr. Pract. 22, 1259–1266 (2016)
C. Reiners, J. Biko, H. Haenscheid, H. Hebestreit, S. Kirinjuk, O. Baranowski, R.J. Marlowe, E. Demidchik, V. Drozd, Y. Demidchik, Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, 3039–3048 (2013)
S.A. Rivkees, E.L. Mazzaferri, F.A. Verburg, C. Reiners, M. Luster, C.K. Breuer, C.A. Dinauer, R. Udelsman, The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr. Rev. 32, 798–826 (2011)
D. Handkiewicz-Junak, J. Wloch, J. Roskosz, J. Krajewska, A. Kropinska, L. Pomorski, A. Kukulska, A. Prokurat, Z. Wygoda, B. Jarzab, Total thyroidectomy and adjuvant radioactive treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer. J. Nucl. Med. 48, 879–888 (2007)
M. Luster, M. Lassmann, L.S. Freudenberg, C. Reiners, Thyroid cancer: management strategy including dosimetry and long-term results. Hormones (Athens) 6, 269–278 (2007)
L.K. Harding, Radiation protection legislation. Eur. J. Nucl. Med. 25, 187–191 (1988)
B.R. Haugen, E.K. Alexander, K.C. Bible, G.M. Doherty, S.J. Mandel, Y.E. Nikiforov, F. Pacini, G.W. Randolph, A.M. Sawka, M. Schlumberger, K.G. Schuff, S.I. Sherman, J.A. Sosa, D.L. Steward, R.M. Tuttle, L. Wartofsky, 2015 American thyroid association management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016)
M. Dardas, M. Abboud, I. Salti, M. Shoucair, M. Saleh, S. Azar, C. Rodriguez-Galindo, S. Muwakkit, Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution. Pediatr. Hematol. Oncol. 26, 439–447 (2009)
A.E. Bargren, G.Y. Meyer-Rochow, L.W. Delbridge, S.B. Sidhu, H. Chen, Outcomes of surgically managed pediatric thyroid cancer. J. Surg. Res. 156, 70–73 (2009)
C.A. Welch Dinauer, R.M. Tuttle, D.K. Robie, D.R. McClellan, R.L. Sver, C. Adair, G.L. Francis, Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin. Endocrinol (Oxf) 49, 619–628 (1998)
C.H. Huang, T.C. Chao, C. Hseuh, K.J. Lin, T.Y. Ho, S.F. Lin, J.D. Lin, Therapeutic outcome and prognosis in young patients with papillary and follicular thyroid cancer. Pediatr Surg Int 28, 489–494 (2012)
Y. Enomoto, E. Enomoto, S. Uchino, H. Shibuya, S. Watanabe, S. Noguchi, Clinical features, treatment, and long-term outcome of papillary thyroid cancer in children and adolescents without radiation exposure. World J. Surg. 36, 1241–1246 (2012)
J. Mihailovic, K. Nikoletic, D. Srbovan, Recurrent disease in Juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes. J. Nucl. Med. 55, 710–717 (2014)
J.S. Brink, J.A. van Heerden, B. McIver, D.R. Salomao, D.R. Farley, C.S. Grant, G.B. Thompson, D. Zimmerman, I.D. Hay, Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 128, 881–886 (2007)
P.B. Pires, P.A. Alves, M.A. Bordallo, D.A. Bulzico, F.P. Lopes, T. Farias, F. Dias, R.A. Lima, I.C. Santos Gisler, C.M. Coeli, R.V. Carvalhaes de Oliveira, R. Corbo, M. Vaisman, F. Vaisman, Prognostic factors for early and long-term remission in pediatric differentiated thyroid cancer: the role of age, sex, clinical presentation and the newly proposed Americal Thyroid Association Risk stratification system. Thyroid 26, 1480–1487 (2016)
F.T. Hall, N.J. Beasley, S.J. Eski, I.J. Witterick, P.G. Walfish, J.L. Freeman, Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryncoscope 113, 77–81 (2003)
K.A. Heemstra, Y.Y. Liu, M. Stokkel, J. Kievit, E. Corssmit, A.M. Pereira, J.A. Romijn, J.W. Smit, Serum thyroglobulin concentrations predict disease-free and death in differentiated thyroid carcinoma. Clin. Endocrinol. (Oxf) 66, 58–64 (2007)
G. Ronga, M. Filesi, G. Ventroni, A.R. Vestri, A. Signore, Value of the first serum thyroglobulin level after total thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur. J. Nucl. Med. 26, 1448–1452 (1999)
A.M. Samuel, B. Rajashekharrao, D.H. Shah, Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J. Nucl. Med. 39, 1531–1536 (1998)
R. Vassilopoulou-Sellin, M.J. Klein, T.H. Smith, N.A. Samaan, R.A. Frankenthaler, H. Goepfert, A. Cangir, T.P. Haynie, Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 71, 1348–1352 (1993)
J. Biko, C. Reiners, M.C. Kreissl, F.A. Verburg, Y. Demidchik, V. Drozd, Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up. Eur. J. Nucl. Med. Mol. Imaging 38, 651–655 (2011)
Acknowledgements
We would like to thank Dr. Maria-Alexandra Magiakou and Dr. Maria Karantza for referring their patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval
Parents have given their written informed consent. The study protocol has been approved by the Ethics Committee of Evangelismos Hospital.
Consent for publication
All authors have read and approved the manuscript and gave their consent for publication.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Karapanou, O., Tzanela, M., Rondogianni, P. et al. Long-term outcome of differentiated thyroid cancer in children and young adults: risk stratification by ATA criteria and assessment of pre-ablation stimulated thyroglobulin as predictors of disease persistence. Endocrine 70, 566–574 (2020). https://doi.org/10.1007/s12020-020-02378-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-020-02378-2